Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety
| dc.contributor.author | Chandrakantha, B. | |
| dc.contributor.author | Shetty, P. | |
| dc.contributor.author | Nambiyar, V. | |
| dc.contributor.author | Isloor, N. | |
| dc.contributor.author | Isloor, A.M. | |
| dc.date.accessioned | 2026-02-05T09:36:26Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | In the present study a series of new 1,3,4-oxadiazole derivatives containing 2-fluoro-4-methoxy moiety were synthesized. These newly synthesized compounds were characterized by NMR, mass spectral, IR spectral study and also by C, H, N analyses. All the newly synthesized compounds were screened for their antibacterial and antifungal studies. Antimicrobial studies revealed that compounds 4a and 4b showed significant antibacterial activity against Escherichia coli and Pseudomonas aeruginosa Compound 4i showed significant antifungal activity against C. albicans. © 2009 Elsevier Masson SAS. All rights reserved. | |
| dc.identifier.citation | European Journal of Medicinal Chemistry, 2010, 45, 3, pp. 1206-1210 | |
| dc.identifier.issn | 2235234 | |
| dc.identifier.uri | https://doi.org/10.1016/j.ejmech.2009.11.046 | |
| dc.identifier.uri | https://idr.nitk.ac.in/handle/123456789/27492 | |
| dc.subject | 1,3,4 oxadiazole derivative | |
| dc.subject | 2 (2 bromo 5 chlorophenyl) 5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (2 fluoro 4 methoxyphenyl) 5 (2,3,4 trifluorophenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (2 fluoro 4 methoxyphenyl) 5 (3 fluoro 4 nitrophenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (2 fluoro 4 methoxyphenyl) 5 (5 methylisoxazol 3 yl) 1,3,4 oxadiazole | |
| dc.subject | 2 (2 fluoro 4 methoxyphenyl) 5 [2 (trifluoromethyl)phenyl] 1,3,4 oxadiazole | |
| dc.subject | 2 (2,3 difluoro 6 nitrophenyl) 5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (2,3 dimethylphenyl) 5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (3 bromo 2 methylphenyl) 5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (3,5 difluorophenyl) 5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 (4 fluorophenyl) 5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazole | |
| dc.subject | 2 chloro 5 [5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazol 2 yl]pyridine | |
| dc.subject | 3 [5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazol 2 yl]benzonitrile | |
| dc.subject | 3 [5 (2 fluoro 4 methoxyphenyl) 1,3,4 oxadiazol 2 yl]quinoline | |
| dc.subject | antifungal agent | |
| dc.subject | antiinfective agent | |
| dc.subject | benzene derivative | |
| dc.subject | fluconazole | |
| dc.subject | nitrofural | |
| dc.subject | unclassified drug | |
| dc.subject | antibacterial activity | |
| dc.subject | antifungal activity | |
| dc.subject | article | |
| dc.subject | Bacillus subtilis | |
| dc.subject | biological activity | |
| dc.subject | Candida albicans | |
| dc.subject | controlled study | |
| dc.subject | drug synthesis | |
| dc.subject | Escherichia coli | |
| dc.subject | infrared spectroscopy | |
| dc.subject | mass spectrometry | |
| dc.subject | nonhuman | |
| dc.subject | proton nuclear magnetic resonance | |
| dc.subject | Pseudomonas aeruginosa | |
| dc.subject | Staphylococcus aureus | |
| dc.subject | Anti-Bacterial Agents | |
| dc.subject | Anti-Infective Agents | |
| dc.subject | Bacteria | |
| dc.subject | Fluorine | |
| dc.subject | Fungi | |
| dc.subject | Magnetic Resonance Spectroscopy | |
| dc.subject | Microbial Sensitivity Tests | |
| dc.subject | Molecular Structure | |
| dc.subject | Oxadiazoles | |
| dc.subject | Spectrophotometry, Infrared | |
| dc.title | Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety |
